AI assistant
Twist Bioscience Corp — Director's Dealing 2021
Nov 30, 2021
31873_dirs_2021-11-30_bcb195eb-c094-4aa7-b942-5702a9e8681b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-11-16
Reporting Person: Yankton Kevin Bruce (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-16 | Common Stock | A | 1600 | — | Acquired | 3201 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-16 | Employee Stock Option (right to buy) | $115.99 | A | 2551 | Acquired | 2031-11-15 | Common Stock (2551) | Direct |
Footnotes
F1: Represents a restricted stock unit award ("RSU") of which 25% of the total number of RSUs vest on the first anniversary of May 17, 2021 and 1/16th of the total number of RSUs vest on each quarterly anniversary thereafter, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F2: 25% of the shares subject to the option vest and become exercisable on the one (1) year anniversary of May 17, 2021 and 1/48 of the shares subject to the option vest and become exercisable monthly thereafter, subject to the Reporting Person's continuous service through each vesting date.